The Tel Aviv University researchers’ study, published in the journal Translational Psychiatry, describe a gene that codes for a particular protein, leading to neurotransmission. As a result, future therapies should be able to halt its progression.
A recent discovery by researchers at Tel Aviv University may soon change the way Alzheimer’s disease is diagnosed and treated.
The study, published in the journal Translational Psychiatry, describe a gene that codes for a particular protein that researchers discovered.
The protein then turns off signals that it normally produces.
That process, in turn, blocks the brain from moving brain chemicals in their regular manner, also known as neurotransmission, thereby contributing to Alzheimer’s disease. Continue Reading »